![Agenus – CTEP has announced the availability of botensilimab for clinical studies](https://oncodaily.com/pub/uploads/2024/06/IMG_9051-e1719865061998.jpeg)
Photo taken from Agenus/LinkedIn
Jul 1, 2024, 09:12
Agenus – CTEP has announced the availability of botensilimab for clinical studies
Agenus shared on LinkedIn:
“The National Cancer Institute (NCI)‘s Cancer Therapy Evaluation Program (CTEP) has announced the availability of our therapy, botensilimab, for clinical studies. ”.
Read further.
Source: Agenus/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2024, 18:11